Medpace Holdings, Inc.
MEDP
Rang in Aktien
#1301
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Aktienkurs
$622.03
Marktkapitalisierung
$17.36B
Veränderung (1 Tag)
0.38%
Veränderung (1 Jahr)
14.26%
Land
US
Handel Medpace Holdings, Inc. (MEDP)
Kategorie
Healthcare
P/B-Verhältnis für Medpace Holdings, Inc. (MEDP)
P/B-Verhältnis zum October 2026 TTM: 40.23
Laut den neuesten Finanzberichten und dem Aktienkurs von Medpace Holdings, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 40.23. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 12.46.
P/B-Verlauf für Medpace Holdings, Inc. von 2013 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 40.23 | 14.01% |
| 2025 | 35.29 | 183.28% |
| 2024 | 12.46 | -26.06% |
| 2023 | 16.85 | -5.37% |
| 2022 | 17.80 | 117.38% |
| 2021 | 8.19 | 33.05% |
| 2020 | 6.16 | 48.23% |
| 2019 | 4.15 | 30.16% |
| 2018 | 3.19 | 13.44% |
| 2017 | 2.81 | 33.43% |
| 2016 | 2.11 | -20.86% |
| 2015 | 2.66 | 30.90% |
| 2014 | 2.03 | 0.00% |
| 2013 | 0.00 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| 4.7411 | -88.22% |
US
|
|
| 3.0143 | -92.51% |
US
|
|
| 31.051 | -22.82% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | -83.44% |
US
|
